Peptide Record

GHK-Cu · full corpus

Explore

Every evidence record, mention, review and regulatory filing collected for GHK-Cu, in one list. Each row links to the original. Nothing here is summarised for you — this is the corpus, source tag by source tag.

1,202 records · ordered by source hierarchy — human trials first, vendor material last

Corpus records for GHK-Cu
SourceKindRecordAttributionDetailDate
PRECLINICALevidenceFood-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing.Cu-GHK2025-01-01
PRECLINICALevidenceAre We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?GHK-Cu2025-01-01
PRECLINICALevidencePalmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines.GHKPigmentation2025-01-01
PRECLINICALevidenceAre We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?GHKSkin appearance & aging2025-01-01
PRECLINICALevidenceFood-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing.GHK2025-01-01
PRECLINICALevidenceTopically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.GHK2025-01-01
PRECLINICALevidenceExploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.GHK2025-01-01
PRECLINICALevidenceExploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.GHK2025-01-01
PRECLINICALevidenceEpithelial Interleukin-1 Receptor-Like-1 Activation Is Contingent on Interleukin-33 Isoforms and Asthma-Related Receptor Variation.GHK2024-12-01
PRECLINICALevidenceThe naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function.GHK2024-12-01
PRECLINICALevidenceEfficient Treatment of Psoriasis Using Conditioned Media from Mesenchymal Stem Cell Spheroids Cultured to Produce Transforming Growth Factor-beta1-Enriched Small-Sized Extracellular Vesicles.GHK2024-11-30
PRECLINICALevidenceNovel Applications of CE-ICP-MS/MS: Monitoring of Antiaging GHK-Cu Cosmetic Component Encapsulation in Liposomes.GHK2024-11-01
PRECLINICALevidenceNovel Applications of CE-ICP-MS/MS: Monitoring of Antiaging GHK-Cu Cosmetic Component Encapsulation in Liposomes.Copper tripeptide2024-11-01
PRECLINICALevidenceA self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery.GHK2024-09-25
PRECLINICALevidenceThe glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.GHK-Cu2024-09-01
PRECLINICALevidenceThe glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.GHKLongevity & cellular aging2024-09-01
PRECLINICALevidenceAn Assessment of the Safety, Efficacy, and Tolerability of a Novel Scalp Treatment Regimen Combining a Hydroxy Acid-Based Scrub and Copper Tripeptide Serum in the Management of Seborrheic Dermatitis in Adults.Copper tripeptide-12024-09-01
PRECLINICALevidenceGlycyl-l-histidyl-l-lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro.GHK2024-05-02
PRECLINICALevidenceRigid-flexible nanocarriers loaded with active peptides for antioxidant and anti-inflammatory applications in skin.GHK-Cu2024-04-01
PRECLINICALevidenceRigid-flexible nanocarriers loaded with active peptides for antioxidant and anti-inflammatory applications in skin.GHK2024-04-01
PRECLINICALevidenceTripeptides Ghk and GhkCu-modified silver nanoparticles for enhanced antibacterial and wound healing activities.GHK2024-04-01
PRECLINICALevidenceEvaluation of GHK peptide-heparin interactions in multifunctional liposomal covering.GHK2024-03-01
PRECLINICALevidenceThermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application.GHK-Cu2024-02-01
PRECLINICALevidenceThermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application.GHK2024-02-01
PRECLINICALevidenceBehavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide.GHK-Cu2024-01-01
PRECLINICALevidenceBehavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide.GHK2024-01-01
PRECLINICALevidenceDesign, synthesis, and characterization of type I collagen mimetic peptides.GHK2024-01-01
PRECLINICALevidenceAn epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.GHK2023-12-07
PRECLINICALevidenceA combination of three antioxidants decreases the impact of rural particulate pollution in Normal human keratinocytes.GHK2023-12-01
PRECLINICALevidenceIn situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing.GHK2023-12-01
PRECLINICALevidenceIn situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing.Cu-GHK2023-12-01
PRECLINICALevidenceBehavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide.GHK2023-11-21
PRECLINICALevidenceBehavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide.GHK-Cu2023-11-21
PRECLINICALevidenceIntranasal GHK peptide enhances resilience to cognitive decline in aging mice.GHK2023-11-17
PRECLINICALevidenceIntranasal GHK peptide enhances resilience to cognitive decline in aging mice.GHK-Cu2023-11-17
PRECLINICALevidencePhenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications.GHK-Cu2023-11-03
PRECLINICALevidencePhenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications.GHK2023-11-03
PRECLINICALevidenceLiposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application.Copper tripeptide2023-10-18
PRECLINICALevidenceLiposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application.GHK2023-10-18
PRECLINICALevidenceEffect of Peptides on the Synthesis, Properties and Wound Healing Capacity of Silver Nanoparticles.Copper tripeptide-12023-10-16
PRECLINICALevidencePacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis.GHK2023-10-10
PRECLINICALevidenceNew Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders.GHK2023-09-20
PRECLINICALevidenceUltrasensitive and Label-Free Detection of Copper Ions by GHK-Modified Asymmetric Nanochannels.GHK-Cu2023-09-12
PRECLINICALevidenceUltrasensitive and Label-Free Detection of Copper Ions by GHK-Modified Asymmetric Nanochannels.GHK2023-09-12
PRECLINICALevidenceSynergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests.GHK-Cu2023-09-01
PRECLINICALevidenceSynergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests.GHKSkin appearance & aging · preclinical2023-09-01
PRECLINICALevidenceDistinction between rhinitis alone and rhinitis with asthma using interactomics.GHK2023-08-12
PRECLINICALevidenceRelief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex via activation of SIRT1 in airway epithelial cells.GHK2023-08-01
PRECLINICALevidenceRelief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex via activation of SIRT1 in airway epithelial cells.GHK-Cu2023-08-01
PRECLINICALevidenceMulti working mode SPR chip laboratory for high refractive index detection.GHK-Cu2023-06-19